Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, Morrison JH, Gold G, Hof PR. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology. 2003;60(9):1495–500.

Article  CAS  PubMed  Google Scholar 

Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 2009;118(1):53–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Calignon A, Spires-Jones TL, Pitstick R, Carlson GA, Hyman BT. Tangle-bearing neurons survive despite disruption of membrane integrity in a mouse model of tauopathy. J Neuropathol Exp Neurol. 2009;68(7):757–61.

Article  PubMed  Google Scholar 

Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K. Hyperphosphorylation induces self-assembly of Tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci U S A. 2001;98(12):6923–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spires-Jones TL, Kopeikina KJ, Koffie RM, de Calignon A, Hyman BT. Are tangles as toxic as they look? J Mol Neurosci. 2011;45(3):438–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alonso Adel C, Li B, Grundke-Iqbal I, Iqbal K. Polymerization of hyperphosphorylated Tau into filaments eliminates its inhibitory activity. Proc Natl Acad Sci U S A. 2006;103(23):8864–9.

Article  PubMed  Google Scholar 

Nachman E, Wentink AS, Madiona K, Bousset L, Katsinelos T, Allinson K, Kampinga H, McEwan WA, Jahn TR, Melki R, Mogk A, Bukau B, Nussbaum-Krammer C. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species. J Biol Chem. 2020;295(28):9676–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castillo-Carranza DL, Gerson JE, Sengupta U, Guerrero-Munoz MJ, Lasagna-Reeves CA, Kayed R. Specific targeting of Tau oligomers in Htau mice prevents cognitive impairment and Tau toxicity following injection with brain-derived Tau oligomeric seeds. J Alzheimers Dis. 2014;40(Suppl 1):S97–111.

Article  PubMed  Google Scholar 

Gibbons GS, Kim SJ, Wu Q, Riddle DM, Leight SN, Changolkar L, Xu H, Meymand ES, O’Reilly M, Zhang B, Brunden KR, Trojanowski JQ, Lee VMY. Conformation-selective Tau monoclonal antibodies inhibit Tau pathology in primary neurons and a mouse model of Alzheimer’s disease. Mol Neurodegener. 2020;15(1):64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener. 2011;6:39.

Article  PubMed  PubMed Central  Google Scholar 

Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR, Kayed R. Identification of oligomers at early stages of Tau aggregation in Alzheimer’s disease. FASEB J. 2012;26(5):1946–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

d’Orange M, Auregan G, Cheramy D, Gaudin-Guerif M, Lieger S, Guillermier M, Stimmer L, Josephine C, Herard AS, Gaillard MC, Petit F, Kiessling MC, Schmitz C, Colin M, Buee L, Panayi F, Diguet E, Brouillet E, Hantraye P, Bemelmans AP, Cambon K. Potentiating tangle formation reduces acute toxicity of soluble Tau species in the rat. Brain. 2018;141(2):535–49.

Article  PubMed  Google Scholar 

Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Kiritoshi T, Neugebauer V, Jackson GR, Kayed R. Alzheimer brain-derived Tau oligomers propagate pathology from endogenous Tau. Sci Rep. 2012;2:700.

Article  PubMed  PubMed Central  Google Scholar 

Maeda S, Takashima A. Tau Oligomers Adv Exp Med Biol. 2019;1184:373–80.

Colom-Cadena M, Davies C, Sirisi S, Lee JE, Simzer EM, Tzioras M, Querol-Vilaseca M, Sanchez-Aced E, Chang YY, Holt K, McGeachan RI, Rose J, Tulloch J, Wilkins L, Smith C, Andrian T, Belbin O, Pujals S, Horrocks MH, Lleo A, Spires-Jones TL. Synaptic oligomeric Tau in Alzheimer’s disease - A potential culprit in the spread of Tau pathology through the brain. Neuron. 2023;111(14):2170–83. e6.

Article  CAS  PubMed  Google Scholar 

Fa M, Puzzo D, Piacentini R, Staniszewski A, Zhang H, Baltrons MA, Li Puma DD, Chatterjee I, Li J, Saeed F, Berman HL, Ripoli C, Gulisano W, Gonzalez J, Tian H, Costa JA, Lopez P, Davidowitz E, Yu WH, Haroutunian V, Brown LM, Palmeri A, Sigurdsson EM, Duff KE, Teich AF, Honig LS, Sierks M, Moe JG, D’Adamio L, Grassi C, Kanaan NM, Fraser PE, Arancio O. Extracellular Tau oligomers produce an immediate impairment of LTP and memory. Sci Rep. 2016;6:19393.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puzzo D, Piacentini R, Fa M, Gulisano W, Li Puma DD, Staniszewski A, Zhang H, Tropea MR, Cocco S, Palmeri A, Fraser P, D’Adamio L, Grassi C, Arancio O. LTP and memory impairment caused by extracellular Abeta and Tau oligomers is APP-dependent. Elife. 2017;6:e26991.

Article  PubMed  PubMed Central  Google Scholar 

Ondrejcak T, Klyubin I, Hu NW, Yang Y, Zhang Q, Rodriguez BJ, Rowan MJ. Rapidly reversible persistent LTP Inhibition by patient-derived brain Tau and amyloid ß proteins. Phil Trans R Soc B. 2024;379:20230234.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guerrero-Munoz MJ, Gerson J, Castillo-Carranza DL. Tau oligomers: the toxic player at synapses in Alzheimer’s disease. Front Cell Neurosci. 2015;9:464.

Article  PubMed  PubMed Central  Google Scholar 

Castillo-Carranza DL, Nilson AN, Van Skike CE, Jahrling JB, Patel K, Garach P, Gerson JE, Sengupta U, Abisambra J, Nelson P, Troncoso J, Ungvari Z, Galvan V, Kayed R. Cerebral microvascular accumulation of Tau oligomers in Alzheimer’s disease and related tauopathies. Aging Dis. 2017;8(3):257–66.

Article  PubMed  PubMed Central  Google Scholar 

Sengupta U, Portelius E, Hansson O, Farmer K, Castillo-Carranza D, Woltjer R, Zetterberg H, Galasko D, Blennow K, Kayed R. Tau oligomers in cerebrospinal fluid in Alzheimer’s disease. Ann Clin Transl Neurol. 2017;4(4):226–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kolarova M, Sengupta U, Bartos A, Ricny J, Kayed R. Tau oligomers in Sera of patients with Alzheimer’s disease and aged controls. J Alzheimers Dis. 2017;58(2):471–8.

Article  CAS  PubMed  Google Scholar 

Mate de Gerando A, Khasnavis A, Welikovitch LA, Bhavsar H, Glynn C, Quittot N, Perbet R, Hyman BT. Aqueous extractable nonfibrillar and Sarkosyl extractable fibrillar Alzheimer’s disease Tau seeds have distinct properties. Acta Neuropathol Commun. 2024;12(1):145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, Jean-Gilles D, Clark R, Atchison K, Moore R, Chibnik LB, Tanzi RE, Frosch MP, Serrano-Pozo A, Elwood F, Steen JA, Kennedy ME, Hyman BT. Author correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease. Nat Med. 2021;27(2):356.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV, He Z, Zhang B, Gathagan RJ, Trojanowski JQ, Lee VMY. Pathological Tau strains from human brains recapitulate the diversity of tauopathies in nontransgenic mouse brain. J Neurosci. 2017;37(47):11406–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo JL, Narasimhan S, Changolkar L, He Z, Stieber A, Zhang B, Gathagan RJ, Iba M, McBride JD, Trojanowski JQ, Lee VM. Unique pathological Tau conformers from Alzheimer’s brains transmit Tau pathology in nontransgenic mice. J Exp Med. 2016;213(12):2635–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bittar A, Al-Lahham R, Bhatt N, Moore K, Montalbano M, Jerez C, Fung L, McAllen S, Ellsworth A, Kayed R. Passive immunotherapy targeting Tau oligomeric strains reverses tauopathy phenotypes in aged Human-Tau mice in a mouse Model-Specific manner. J Alzheimers Dis. 2022;90(3):1103–22.

Article  CAS  PubMed  Google Scholar 

Hitt BD, Gupta A, Singh R, Yang T, Beaver JD, Shang P, White CL 3rd, Joachimiak LA, Diamond MI. Anti-tau antibodies targeting a conformation-dependent epitope selectiv